Skip to main content
Top
Published in: Child's Nervous System 2/2016

01-02-2016 | Case Report

Cavernous angioma after chemotherapy for desmoplastic/nodular medulloblastoma associated with anhidrotic ectodermal dysplasia

Authors: Fumiyuki Yamasaki, Takeshi Takayasu, Ryo Nosaka, Hiroshi Kawaguchi, Kazuhiko Sugiyama, Masao Kobayashi, Kaoru Kurisu

Published in: Child's Nervous System | Issue 2/2016

Login to get access

Abstract

Purpose

While cavernous angioma (CVA) after cranial irradiation has been documented, its development after high-dose chemotherapy with autologous peripheral blood stem cell transplantation (PBSCT) has not. We present a patient with desmoplastic/nodular medulloblastoma (DNMB) associated with anhidrotic ectodermal dysplasia (AED) who developed CVA 2 years after high-dose chemotherapy and PBSCT.

Methods

A 1-year-old boy with ingravescent vomiting was admitted to our institute. He presented with a large head, a depressed nasal bridge, low-set ears, thick lips with peg-shaped teeth, hypohidrosis, sparse hair, thin atrophic skin, scaly dermatitis with frontal bossing, and a bulging anterior fontanel. Neuroradiological examination revealed multiple cerebellar masses with heterogeneous enhancement and speckled calcifications and severe obstructive hydrocephalus. The histological diagnosis of surgical specimens was DNMB, and he underwent postoperative multiple-drug chemotherapy with autologous PBSCT. The outcome was favorable and he did not undergo radiotherapy.

Results

After 2 years, intracranial hemorrhage was detected at his regular radiological check-up and he again underwent surgery. The histological diagnosis was CVA.

Conclusions

To our knowledge, this is the first report of AED-associated DNMB and CVA.
Literature
1.
go back to reference Yamasaki F, Takayasu T, Nosaka R, Kenjo M, Akiyama Y, Tominaga A, Sugiyama K, Kobayashi M, Kurisu K (2015) The postirradiation incidence of cavernous angioma is higher in patients with childhood pineoblastoma or primitive neuroectodermal tumors than medulloblastoma. Childs Nerv Syst 31:901–907 Yamasaki F, Takayasu T, Nosaka R, Kenjo M, Akiyama Y, Tominaga A, Sugiyama K, Kobayashi M, Kurisu K (2015) The postirradiation incidence of cavernous angioma is higher in patients with childhood pineoblastoma or primitive neuroectodermal tumors than medulloblastoma. Childs Nerv Syst 31:901–907
2.
go back to reference Watanabe Y, Yamasaki F, Nakamura K, Kajiwara Y, Takayasu T, Hirose K, Amatya VJ, Sugiyama K, Kobayashi M, Kurisu K (2013) Desmoplastic/nodular medulloblastoma associated with anhidrotic ectodermal dysplasia. Int Cancer Conf J 2:178–182CrossRef Watanabe Y, Yamasaki F, Nakamura K, Kajiwara Y, Takayasu T, Hirose K, Amatya VJ, Sugiyama K, Kobayashi M, Kurisu K (2013) Desmoplastic/nodular medulloblastoma associated with anhidrotic ectodermal dysplasia. Int Cancer Conf J 2:178–182CrossRef
4.
go back to reference Priolo M, Silengo M, Lerone M, Ravazzolo R (2000) Ectodermal dysplasias: not only ‘skin’ deep. Clin Genet 58:415–430CrossRefPubMed Priolo M, Silengo M, Lerone M, Ravazzolo R (2000) Ectodermal dysplasias: not only ‘skin’ deep. Clin Genet 58:415–430CrossRefPubMed
5.
go back to reference Rigamonti D, Hadley MN, Drayer BP, Johnson PC, Hoenig-Rigamonti K, Knight JT, Spetzler RF (1988) Cerebral cavernous malformations. Incidence and familial occurrence. N Engl J Med 319:343–347CrossRefPubMed Rigamonti D, Hadley MN, Drayer BP, Johnson PC, Hoenig-Rigamonti K, Knight JT, Spetzler RF (1988) Cerebral cavernous malformations. Incidence and familial occurrence. N Engl J Med 319:343–347CrossRefPubMed
6.
go back to reference Lew SM, Morgan JN, Psaty E, Lefton DR, Allen JC, Abbott R (2006) Cumulative incidence of radiation-induced cavernomas in long-term survivors of medulloblastoma. J Neurosurg 104:103–107PubMed Lew SM, Morgan JN, Psaty E, Lefton DR, Allen JC, Abbott R (2006) Cumulative incidence of radiation-induced cavernomas in long-term survivors of medulloblastoma. J Neurosurg 104:103–107PubMed
7.
go back to reference Vinchon M, Leblond P, Caron S, Delestret I, Baroncini M, Coche B (2011) Radiation-induced tumors in children irradiated for brain tumor: a longitudinal study. Childs Nerv Syst 27:445–453CrossRefPubMed Vinchon M, Leblond P, Caron S, Delestret I, Baroncini M, Coche B (2011) Radiation-induced tumors in children irradiated for brain tumor: a longitudinal study. Childs Nerv Syst 27:445–453CrossRefPubMed
8.
go back to reference Burn S, Gunny R, Phipps K, Gaze M, Hayward R (2007) Incidence of cavernoma development in children after radiotherapy for brain tumors. J Neurosurg 106:379–383PubMed Burn S, Gunny R, Phipps K, Gaze M, Hayward R (2007) Incidence of cavernoma development in children after radiotherapy for brain tumors. J Neurosurg 106:379–383PubMed
9.
go back to reference Kerbel RS, Viloria-Petit A, Klement G, Rak J (2000) ‘Accidental’ anti-angiogenic drugs. Anti-oncogene directed signal transduction inhibitors and conventional chemotherapeutic agents as examples. Eur J Cancer 36:1248–1257CrossRefPubMed Kerbel RS, Viloria-Petit A, Klement G, Rak J (2000) ‘Accidental’ anti-angiogenic drugs. Anti-oncogene directed signal transduction inhibitors and conventional chemotherapeutic agents as examples. Eur J Cancer 36:1248–1257CrossRefPubMed
10.
go back to reference Belotti D, Vergani V, Drudis T, Borsotti P, Pitelli MR, Viale G, Giavazzi R, Taraboletti G (1996) The microtubule-affecting drug paclitaxel has antiangiogenic activity. Clin Cancer Res 2:1843–1849PubMed Belotti D, Vergani V, Drudis T, Borsotti P, Pitelli MR, Viale G, Giavazzi R, Taraboletti G (1996) The microtubule-affecting drug paclitaxel has antiangiogenic activity. Clin Cancer Res 2:1843–1849PubMed
11.
go back to reference Vacca A, Iurlaro M, Ribatti D, Minischetti M, Nico B, Ria R, Pellegrino A, Dammacco F (1999) Antiangiogenesis is produced by nontoxic doses of vinblastine. Blood 94:4143–4155PubMed Vacca A, Iurlaro M, Ribatti D, Minischetti M, Nico B, Ria R, Pellegrino A, Dammacco F (1999) Antiangiogenesis is produced by nontoxic doses of vinblastine. Blood 94:4143–4155PubMed
12.
go back to reference Clements MK, Jones CB, Cumming M, Daoud SS (1999) Antiangiogenic potential of camptothecin and topotecan. Cancer Chemother Pharmacol 44:411–416CrossRefPubMed Clements MK, Jones CB, Cumming M, Daoud SS (1999) Antiangiogenic potential of camptothecin and topotecan. Cancer Chemother Pharmacol 44:411–416CrossRefPubMed
13.
go back to reference Miller KD, Sweeney CJ, Sledge GW Jr (2001) Redefining the target: chemotherapeutics as antiangiogenics. J Clin Oncol 19:1195–1206PubMed Miller KD, Sweeney CJ, Sledge GW Jr (2001) Redefining the target: chemotherapeutics as antiangiogenics. J Clin Oncol 19:1195–1206PubMed
14.
go back to reference Doll DC, Yarbro JW (1992) Vascular toxicity associated with antineoplastic agents. Semin Oncol 19:580–596PubMed Doll DC, Yarbro JW (1992) Vascular toxicity associated with antineoplastic agents. Semin Oncol 19:580–596PubMed
15.
go back to reference Licciardello JT, Moake JL, Rudy CK, Karp DD, Hong WK (1985) Elevated plasma von Willebrand factor levels and arterial occlusive complications associated with cisplatin-based chemotherapy. Oncology 42:296–300CrossRefPubMed Licciardello JT, Moake JL, Rudy CK, Karp DD, Hong WK (1985) Elevated plasma von Willebrand factor levels and arterial occlusive complications associated with cisplatin-based chemotherapy. Oncology 42:296–300CrossRefPubMed
16.
go back to reference Roca E, Bruera E, Politi PM, Barugel M, Cedaro L, Carraro S, Chacon RD (1985) Vinca alkaloid-induced cardiovascular autonomic neuropathy. Cancer Treat Rep 69:149–151PubMed Roca E, Bruera E, Politi PM, Barugel M, Cedaro L, Carraro S, Chacon RD (1985) Vinca alkaloid-induced cardiovascular autonomic neuropathy. Cancer Treat Rep 69:149–151PubMed
17.
go back to reference Hansen SW, Olsen N, Rossing N, Rorth M (1990) Vascular toxicity and the mechanism underlying Raynaud’s phenomenon in patients treated with cisplatin, vinblastine and bleomycin. Ann Oncol 1:289–292CrossRefPubMed Hansen SW, Olsen N, Rossing N, Rorth M (1990) Vascular toxicity and the mechanism underlying Raynaud’s phenomenon in patients treated with cisplatin, vinblastine and bleomycin. Ann Oncol 1:289–292CrossRefPubMed
19.
go back to reference Poussaint TY, Siffert J, Barnes PD, Pomeroy SL, Goumnerova LC, Anthony DC, Sallan SE, Tarbell NJ (1995) Hemorrhagic vasculopathy after treatment of central nervous system neoplasia in childhood: diagnosis and follow-up. AJNR Am J Neuroradiol 16:693–699PubMed Poussaint TY, Siffert J, Barnes PD, Pomeroy SL, Goumnerova LC, Anthony DC, Sallan SE, Tarbell NJ (1995) Hemorrhagic vasculopathy after treatment of central nervous system neoplasia in childhood: diagnosis and follow-up. AJNR Am J Neuroradiol 16:693–699PubMed
21.
go back to reference Cheung YT, Chui WK, Chan A (2012) Neuro-cognitive impairment in breast cancer patients: pharmacological considerations. Crit Rev Oncol Hematol 83:99–111CrossRefPubMed Cheung YT, Chui WK, Chan A (2012) Neuro-cognitive impairment in breast cancer patients: pharmacological considerations. Crit Rev Oncol Hematol 83:99–111CrossRefPubMed
22.
go back to reference van Dam FS, Schagen SB, Muller MJ, Boogerd W, vd Wall E, Droogleever Fortuyn ME, Rodenhuis S (1998) Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J Natl Cancer Inst 90:210–218CrossRefPubMed van Dam FS, Schagen SB, Muller MJ, Boogerd W, vd Wall E, Droogleever Fortuyn ME, Rodenhuis S (1998) Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J Natl Cancer Inst 90:210–218CrossRefPubMed
Metadata
Title
Cavernous angioma after chemotherapy for desmoplastic/nodular medulloblastoma associated with anhidrotic ectodermal dysplasia
Authors
Fumiyuki Yamasaki
Takeshi Takayasu
Ryo Nosaka
Hiroshi Kawaguchi
Kazuhiko Sugiyama
Masao Kobayashi
Kaoru Kurisu
Publication date
01-02-2016
Publisher
Springer Berlin Heidelberg
Published in
Child's Nervous System / Issue 2/2016
Print ISSN: 0256-7040
Electronic ISSN: 1433-0350
DOI
https://doi.org/10.1007/s00381-015-2848-6

Other articles of this Issue 2/2016

Child's Nervous System 2/2016 Go to the issue